Expanding the Phenotypic Spectrum of the Recurrent De Novo FBXO31 p. Asp334Asn Variant: Evidence for a Novel Neurodevelopmental Disorder (Kruer Syndrome)
Clinical Genetics · 2026
DOI: 10.1111/cge.70166 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Genetics, 2026. Verfasst von Carolina I Galaz-Montoya und 16 weiteren Autor:innen. Beteiligte Einrichtung: University of Arizona College of Medicine, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: F-Box Proteins, Neurodevelopmental Disorders, Tumor Suppressor Proteins, Intellectual Disability. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Else Kröner-Fresenius Foundation (Germany), Technical University of Munich (TUM), Institute for Advanced Study, European Joint Programme on Rare Diseases (EJP RD).
Abstract (Originalsprache)
Biallelic loss‐of‐function variants in FBXO31 cause autosomal‐recessive intellectual disability. A recurrent de novo variant, c.1000G>A(p.Asp334Asn), has been described in association with an autosomal‐dominant phenotype. To refine this phenotype and its clinical implications, we re‐evaluated three published cases and ascertained four additional probands via advocacy networks, GeneMatcher, and clinician referral. Phenotyping included neurologic, behavioral, and dysmorphology assessment. All seven individuals carried the recurrent de novo FBXO31 p.Asp334Asn variant. A core neurodevelopmental profile was observed and included cerebral palsy (mixed hypotonia, spasticity, and dystonia), global developmental delay/intellectual disability, and speech impairment. Neuropsychiatric features were sometimes prominent and included attention‐deficit/hyperactivity disorder, anxiety, stereotypies, autistic features, and behavioral dysregulation. Neuroimaging often showed a hypoplastic corpus callosum and posterior‐predominant white‐matter changes. In one individual, gray matter heterotopias were also observed. A subtle but consistent facial gestalt was noted. Recurrent FBXO31 p.Asp334Asn variants lead to a recognizable neurodevelopmental syndrome. Based on our findings, we recommend including FBXO31 in diagnostic algorithms for cerebral palsy and neurodevelopmental disorders. We propose the descriptive term “autosomal dominant FBXO31‐associated neurodevelopmental disorder,” and—consistent with the validating laboratory and with support from the FBXO31 Foundation—propose the eponym “Kruer syndrome.”
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Arizona College of Medicine, Phoenix, Arizona, USA.
- Banner University Medical Center, Tucson, Arizona, USA.
- Phoenix Children's, Phoenix, Arizona, USA.
- Advocate Children's Hospital, Park Ridge, Illinois, USA.
- La Pitié-Salpêtrière Hospital, Paris, France.
- Hôpital Trousseau, Paris, France.
ORCID-Profile: Pritha Bisarad, Michael Zech
Förderung
- Else Kröner-Fresenius Foundation (Germany)
- Technical University of Munich (TUM), Institute for Advanced Study
- European Joint Programme on Rare Diseases (EJP RD)
- NINDS NIH HHS
- Technische Universität München
- Cerebral Palsy Alliance Research Foundation
Zitieren
APA
Galaz-Montoya, C. I., Lewis, S. A., Galindo, M. K., Cornejo, P., Skidmore, P. T., Bisarad, P., Magee, H., Bontempo, K., Keren, B., Afenjar, A., Skorvanek, M., Zech, M., Wentzensen, I. M., Gurnett, C. A., Chung, W. K., Bakhtiari, S., & Kruer, M. C. (2026). Expanding the Phenotypic Spectrum of the Recurrent De Novo FBXO31 p. Asp334Asn Variant: Evidence for a Novel Neurodevelopmental Disorder (Kruer Syndrome). Clinical Genetics. https://doi.org/10.1111/cge.70166
Vancouver
Galaz-Montoya CI, Lewis SA, Galindo MK, Cornejo P, Skidmore PT, Bisarad P, et al. Expanding the Phenotypic Spectrum of the Recurrent De Novo FBXO31 p. Asp334Asn Variant: Evidence for a Novel Neurodevelopmental Disorder (Kruer Syndrome). Clinical Genetics. 2026. doi:10.1111/cge.70166
BibTeX
@article{GalazMontoya2026,
author = {Galaz-Montoya, Carolina I and Lewis, Sara A and Galindo, Maureen K and Cornejo, Patricia and Skidmore, Peter T and Bisarad, Pritha and Magee, Helen and Bontempo, Kelly and Keren, Boris and Afenjar, Alexandra and Skorvanek, Matej and Zech, Michael and Wentzensen, Ingrid M and Gurnett, Christina A and Chung, Wendy K and Bakhtiari, Somayeh and Kruer, Michael C},
title = {Expanding the Phenotypic Spectrum of the Recurrent De Novo FBXO31 p. Asp334Asn Variant: Evidence for a Novel Neurodevelopmental Disorder (Kruer Syndrome)},
journal = {Clinical Genetics},
year = {2026},
doi = {10.1111/cge.70166}
}
EUVIMED